GURUFOCUS.COM » STOCK LIST » USA » NAS » United Therapeutics Corp (NAS:UTHR) » Definitions » Days Inventory
Switch to:

United Therapeutics Days Inventory

: 273.60 (As of Jun. 2022)
View and export this data going back to 1999. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). United Therapeutics's Average Total Inventories for the three months ended in Jun. 2022 was $89 Mil. United Therapeutics's Cost of Goods Sold for the three months ended in Jun. 2022 was $30 Mil. Hence, United Therapeutics's Days Inventory for the three months ended in Jun. 2022 was 273.60.

The historical rank and industry rank for United Therapeutics's Days Inventory or its related term are showing as below:

UTHR' s Days Inventory Range Over the Past 10 Years
Min: 118.32   Med: 285.15   Max: 455.12
Current: 283.89

During the past 13 years, United Therapeutics's highest Days Inventory was 455.12. The lowest was 118.32. And the median was 285.15.

UTHR's Days Inventory is ranked worse than
69.27% of 602 companies
in the Biotechnology industry
Industry Median: 175.63 vs UTHR: 283.89

United Therapeutics's Days Inventory increased from Jun. 2021 (223.34) to Jun. 2022 (273.60). It might indicate that United Therapeutics's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. United Therapeutics's Inventory Turnover for the three months ended in Jun. 2022 was 0.33.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. United Therapeutics's Inventory-to-Revenue for the three months ended in Jun. 2022 was 0.19.


United Therapeutics Days Inventory Historical Data

The historical data trend for United Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Days Inventory
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 358.96 191.87 301.68 303.72 268.61

United Therapeutics Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Days Inventory Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 223.34 307.35 251.20 320.61 273.60

Competitive Comparison

For the Biotechnology subindustry, United Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

United Therapeutics Days Inventory Distribution

For the Biotechnology industry and Healthcare sector, United Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where United Therapeutics's Days Inventory falls into.



United Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

United Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as

Days Inventory (A: Dec. 2021 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2020 ) + Total Inventories (A: Dec. 2021 )) / count ) / Cost of Goods Sold (A: Dec. 2021 )*Days in Period
=( (86.5 + 93.8) / 2 ) / 122.5*365
=90.15 / 122.5*365
=268.61

United Therapeutics's Days Inventory for the quarter that ended in Jun. 2022 is calculated as:

Days Inventory (Q: Jun. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Mar. 2022 ) + Total Inventories (Q: Jun. 2022 )) / count ) / Cost of Goods Sold (Q: Jun. 2022 )*Days in Period
=( (88.2 + 89.9) / 2 ) / 29.7*365 / 4
=89.05 / 29.7*365 / 4
=273.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Therapeutics  (NAS:UTHR) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

United Therapeutics's Inventory Turnover for the three months ended in Jun. 2022 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

United Therapeutics's Inventory to Revenue for the three months ended in Jun. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


United Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


United Therapeutics Business Description

United Therapeutics logo
Traded in Other Exchanges
Address
1040 Spring Street, Silver Spring, MD, USA, 20910
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
Executives
Benkowitz Michael officer: President and COO C/O UNITED THERAPEUTICS CORP 1040 SPRING STREET SILVER SPRING MD 20910
Maxwell Linda director 1040 SPRING STREET SILVER SPRING NC 27709
Thompson Tommy G director 7711 CARONDELET ST. LOUIS MO 63105
Mesa Nilda director C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910
Klein Katherine J director STEINBERG HALL-DIETRICH HALL 3620 LOCUST WALK PHILADELPHIA PA 19104
Giltner Richard director C/O UNITED THERAPEUTICS CORPORTION 1735 CONNECTICUT AVE. NW WASHINGTON DC 20009
Olian Judy D. director 2000 AVENUE OF THE STARS 12TH FL LOS ANGELES CA 90067
Edgemond James officer: CFO and Treasurer 1040 SPRING STREET SILVER SPRING MD 20910
Zaccardelli David officer: EVP & Chief Operating Officer 300 TRI STATE INTERNATIONAL SUITE 272 LINCOLNSHIRE IL 60069
Eli Lilly & Co 10 percent owner LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Ferrari John Maxim officer: CFO & Treasurer 1110 SPRING STREET SILVER SPRING MD 20910
Patusky Christopher director
Hicks Henry Beecher Iii director C/O UNITED THERAPEUTICS CORP 1110 SPRING STREET SILVER SPRINGS MD 20910
Gray R Paul director C/O UNITED THERAPEUTICS CORP 1110 SPRING STREET SILVER SPRINGS MD 20910
Dwek Raymond director

United Therapeutics Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)